139 related articles for article (PubMed ID: 8306348)
1. Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis.
Kobayashi H; Shinohara H; Takeuchi K; Itoh M; Fujie M; Saitoh M; Terao T
Cancer Res; 1994 Feb; 54(3):844-9. PubMed ID: 8306348
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
3. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.
Kobayashi H; Shinohara H; Ohi H; Sugimura M; Terao T; Fujie M
Clin Exp Metastasis; 1994 Mar; 12(2):117-28. PubMed ID: 8306525
[TBL] [Abstract][Full Text] [Related]
4. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models.
Kobayashi H; Shinohara H; Fujie M; Gotoh J; Itoh M; Takeuchi K; Terao T
Int J Cancer; 1995 Nov; 63(3):455-62. PubMed ID: 7591248
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition.
Kobayashi H; Gotoh J; Kanayama N; Hirashima Y; Terao T; Sugino D
Cancer Res; 1995 May; 55(9):1847-52. PubMed ID: 7728751
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
Hall SW; Humphries JE; Gonias SL
J Biol Chem; 1991 Jul; 266(19):12329-36. PubMed ID: 1712017
[TBL] [Abstract][Full Text] [Related]
9. Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells.
Kobayashi H; Fujie M; Shinohara H; Ohi H; Sugimura M; Terao T
Int J Cancer; 1994 May; 57(3):378-84. PubMed ID: 8168999
[TBL] [Abstract][Full Text] [Related]
10. Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent.
Kobayashi H; Shinohara H; Gotoh J; Fujie M; Fujishiro S; Terao T
Br J Cancer; 1995 Nov; 72(5):1131-7. PubMed ID: 7577458
[TBL] [Abstract][Full Text] [Related]
11. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
Anonick PK; Gonias SL
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
[TBL] [Abstract][Full Text] [Related]
12. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
Kobayashi H; Gotoh J; Terao T
Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the cellular binding site for the urinary trypsin inhibitor.
Kobayashi H; Gotoh J; Fujie M; Terao T
J Biol Chem; 1994 Aug; 269(32):20642-7. PubMed ID: 8051163
[TBL] [Abstract][Full Text] [Related]
14. Role of activated protein C in facilitating basement membrane invasion by tumor cells.
Kobayashi H; Moniwa N; Gotoh J; Sugimura M; Terao T
Cancer Res; 1994 Jan; 54(1):261-7. PubMed ID: 8261450
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
Anonick PK; Yoo JK; Webb DJ; Gonias SL
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
[TBL] [Abstract][Full Text] [Related]
16. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
Gonias SL; Figler NL; Braud LL
Blood; 1988 Nov; 72(5):1658-64. PubMed ID: 2460159
[TBL] [Abstract][Full Text] [Related]
17. Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells.
Sugimura M; Kobayashi H; Terao T
Gynecol Oncol; 1994 Mar; 52(3):337-46. PubMed ID: 7512520
[TBL] [Abstract][Full Text] [Related]
18. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.
Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Kanayama N; Takei Y; Saga Y; Suzuki M; Itoh H; Terao T
Int J Cancer; 2003 Apr; 104(3):289-302. PubMed ID: 12569552
[TBL] [Abstract][Full Text] [Related]
19. A novel plasmin-inhibitor inhibits the growth of human tumor xenografts and decreases metastasis number.
Szende B; Okada Y; Tsuda Y; Horvath A; Bökönyi G; Okamoto S; Wanaka K; Kéri G
In Vivo; 2002; 16(5):281-6. PubMed ID: 12494864
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]